[HTML][HTML] Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3
C Xie, C Tiede, X Zhang, C Wang, Z Li, X Xu… - Scientific reports, 2017 - nature.com
Abstract Glypican-3 (GPC3) is a promising new marker for hepatocellular carcinoma, but the
reported values for serum GPC3 differ markedly between currently available kits. Here we …
reported values for serum GPC3 differ markedly between currently available kits. Here we …
Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3.
C Xie, C Tiede, X Zhang, C Wang, Z Li, X Xu… - Scientific …, 2017 - europepmc.org
Abstract Glypican-3 (GPC3) is a promising new marker for hepatocellular carcinoma, but the
reported values for serum GPC3 differ markedly between currently available kits. Here we …
reported values for serum GPC3 differ markedly between currently available kits. Here we …
[PDF][PDF] Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3
C Xie, C Tiede, X Zhang, C Wang, Z Li, X Xu… - core.ac.uk
Results Screening and generation of Affimers against GPC3. Phage display library
screening was performed against immobilized GPC3 protein. Thirty two Affimer clones from …
screening was performed against immobilized GPC3 protein. Thirty two Affimer clones from …
Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3
C Xie, C Tiede, X Zhang, C Wang, Z Li… - Scientific …, 2017 - pubmed.ncbi.nlm.nih.gov
Glypican-3 (GPC3) is a promising new marker for hepatocellular carcinoma, but the reported
values for serum GPC3 differ markedly between currently available kits. Here we isolated …
values for serum GPC3 differ markedly between currently available kits. Here we isolated …
[HTML][HTML] Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3
C Xie, C Tiede, X Zhang, C Wang, Z Li, X Xu… - Scientific …, 2017 - ncbi.nlm.nih.gov
Abstract Glypican-3 (GPC3) is a promising new marker for hepatocellular carcinoma, but the
reported values for serum GPC3 differ markedly between currently available kits. Here we …
reported values for serum GPC3 differ markedly between currently available kits. Here we …
[引用][C] Development of an Affimerantibody combined immunological diagnosis kit for glypican-3
C Xie, C Tiede, X Zhang, C Wang, Z Li… - Scientific …, 2017 - espace.library.uq.edu.au
Glypican-3 (GPC3) is a promising new marker for hepatocellular carcinoma, but the reported
values for serum GPC3 differ markedly between currently available kits. Here we isolated …
values for serum GPC3 differ markedly between currently available kits. Here we isolated …
Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3
C Xie, C Tiede, X Zhang, C Wang, Z Li, X Xu… - Scientific …, 2017 - eprints.whiterose.ac.uk
Glypican-3 (GPC3) is a promising new marker for hepatocellular carcinoma, but the reported
values for serum GPC3 differ markedly between currently available kits. Here we isolated …
values for serum GPC3 differ markedly between currently available kits. Here we isolated …
Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3
C Xie, C Tiede, X Zhang, C Wang, Z Li, X Xu… - Scientific …, 2017 - ui.adsabs.harvard.edu
Abstract Glypican-3 (GPC3) is a promising new marker for hepatocellular carcinoma, but the
reported values for serum GPC3 differ markedly between currently available kits. Here we …
reported values for serum GPC3 differ markedly between currently available kits. Here we …